Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!by Richard Daverman, PhDMay 15, 2013 -- Last week, Amgen and Zhejiang Beta Pharma announced they would form a…
PHILADELPHIA, May 14, 2013 The IP & Science business of Thomson Reuters, the worlds leading provider of intelligent information for businesses and professionals, today announced the release of a…
Amgen and Zhejiang Beta Pharma have signed an agreement to form a joint venture (JV) to commercialize Amgen's Vectibix (panitumumab) in the Chinese market.
The China drug market is getting trickier but that is not stopping the big names of biotech and pharma from plowing ahead with tie-ups of various kinds to sell into the enormous market. Amgen today sa…
